US FDA CDER, CBER Staff Say Pandemic Had Negative Effect On Hiring, Retention
Executive Summary
Human resource managers also worried that since universal teleworking was valued by employees, a return to pre-pandemic conditions could cause a mass exodus.
You may also be interested in...
Operation Warp Speed For Rare Diseases? US FDA Is Considering Pilot Programs
CBER director Peter Marks says the FDA may evaluate giving gene therapy products the ‘degree of responsiveness’ that COVID-19 vaccines received. In a discussion of the pandemic's effects on staff retention, CDER director Patrizia Cavazzoni says attrition rates are back to historical levels.
US FDA May Rethink White Oak Campus As Agency Plots New Normal For Work
A pilot project on the future of work at the FDA could lead to reduced office space requirements and improve recruitment and retention, officials say.
US FDA May Rethink White Oak Campus As Agency Plots ‘New Normal’ For Work
A pilot project on the future of work at the FDA could lead to reduced office space requirements and improve recruitment and retention, officials say.